1-10 of 10
Mats Jerkeman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CD163 + macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression

Joana de Matos Rodrigues, Lavanya Lokhande, Lina M. Olsson, May Hassan, Angelica Johansson, Anna Janská, Darshan Kumar, Lina Schmidt, Anna Nikkarinen, Peter Hollander, Ingrid Glimelius, Anna Porwit, Anna Sandstrom Gerdtsson, Mats Jerkeman, Sara Ek
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4370–4385.
https://doi.org/10.1182/bloodadvances.2023012039
Published: 2024
Includes: Supplemental data
Journal Articles

The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas

Clinical Trials & Observations
Rahul S. Bhansali, Fredrik Ellin, Thomas Relander, Miao Cao, Wenrui Li, Qi Long, Nivetha Ganesan, Robert Stuver, Steven M. Horwitz, Kitsada Wudhikarn, Steven R. Hwang, N. Nora Bennani, Julio Chavez, Lubomir Sokol, Hayder Saeed, Frank Duan, Pierluigi Porcu, Priyanka Pullarkat, Neha Mehta-Shah, Jasmine M. Zain, Miguel Ruiz, Jonathan E. Brammer, Rishab Prakash, Swaminathan P. Iyer, Adam J. Olszewski, Ajay Major, Peter A. Riedell, Sonali M. Smith, Caroline Goldin, Bradley Haverkos, Bei Hu, Tony Z. Zhuang, Pamela B. Allen, Wael Toama, Murali Janakiram, Taylor R. Brooks, Deepa Jagadeesh, Nisha Hariharan, Aaron M. Goodman, Gabrielle Hartman, Paola Ghione, Fatima Fayyaz, Joanna M. Rhodes, Elise A. Chong, James N. Gerson, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Mats Jerkeman, Stefan K. Barta
Journal: Blood Advances
Blood Adv (2024) 8 (13): 3507–3518.
https://doi.org/10.1182/bloodadvances.2024012800
Published: 2024
Includes: Supplemental data
Journal Articles

MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial

Clinical Trials & Observations
Mats Jerkeman, Arne Kolstad, Martin Hutchings, Annika Pasanen, Leo Meriranta, Carsten Utoft Niemann, Rasmus Rask Kragh Jørgensen, Tarec Christoffer El-Galaly, Jon Riise, Sirpa Leppä, Jacob Haaber Christensen, Kristina Sonnevi, Lone Bredo Pedersen, Karin Fahl Wader, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2024) 8 (2): 407–415.
https://doi.org/10.1182/bloodadvances.2023011920
Published: 2024
Includes: Supplemental data
Journal Articles

Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma

Anna Nikkarinen, Lavanya Lokhande, Rose-Marie Amini, Mats Jerkeman, Anna Porwit, Daniel Molin, Gunilla Enblad, Arne Kolstad, Riikka Räty, Martin Hutchings, Caroline E. Weibull, Peter Hollander, Sara Ek, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5304–5313.
https://doi.org/10.1182/bloodadvances.2023010052
Published: 2023
Includes: Supplemental data
Journal Articles

Late effects in patients with mantle cell lymphoma treated with or without autologous stem cell transplantation

Clinical Trials & Observations
Sara Ekberg, Karin E. Smedby, Alexandra Albertsson-Lindblad, Mats Jerkeman, Caroline E. Weibull, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2023) 7 (5): 866–874.
https://doi.org/10.1182/bloodadvances.2022007241
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of comorbidity in older patients with peripheral T-cell lymphoma: an international retrospective analysis of 891 patients

Clinical Trials & Observations
Monica Mead, Henrik Cederleuf, Maja Björklund, Xiaoyan Wang, Thomas Relander, Mats Jerkeman, Daria Gaut, Sarah Larson, Fredrik Ellin
Journal: Blood Advances
Blood Adv (2022) 6 (7): 2120–2128.
https://doi.org/10.1182/bloodadvances.2021004269
Published: 2022
Journal Articles

Unmarried or less-educated patients with mantle cell lymphoma are less likely to undergo a transplant, leading to lower survival

Clinical Trials & Observations
Ingrid Glimelius, Karin E. Smedby, Alexandra Albertsson-Lindblad, Michael J. Crowther, Sandra Eloranta, Mats Jerkeman, Caroline E. Weibull
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1638–1647.
https://doi.org/10.1182/bloodadvances.2020003645
Published: 2021
Includes: Supplemental data
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data
Journal Articles

Valproate in combination with rituximab and CHOP as first-line therapy in diffuse large B-cell lymphoma (VALFRID)

Clinical Trials & Observations
Kristina Drott, Hans Hagberg, Karin Papworth, Thomas Relander, Mats Jerkeman
Journal: Blood Advances
Blood Adv (2018) 2 (12): 1386–1392.
https://doi.org/10.1182/bloodadvances.2018019240
Published: 2018
Includes: Supplemental data
Journal Articles

Crosstalk between ROR1 and BCR pathways defines novel treatment strategies in mantle cell lymphoma

Hanna Karvonen, David Chiron, Wilhelmiina Niininen, Sara Ek, Mats Jerkeman, Elaheh Moradi, Matti Nykter, Caroline A. Heckman, Olli Kallioniemi, Astrid Murumägi, Daniela Ungureanu
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2257–2268.
https://doi.org/10.1182/bloodadvances.2017010215
Published: 2017
Includes: Supplemental data